Page last updated: 2024-10-22

amfenac and Dry Eye

amfenac has been researched along with Dry Eye in 1 studies

amfenac: RN given refers to parent cpd; structure
amfenac : An oxo monocarboxylic acid that is benzophenone in which one of the phenyl groups is substituted by an amino group and a carboxymethyl group at position 2 and 3, respectively. The corresponding carboxamide, nepafenac, is a prodrug of amfenac and is used for the treatment of pain and inflammation following cataract surgery.

Research Excerpts

ExcerptRelevanceReference
"We have developed a rapid and straightforward topical treatment method for dry eye disease (DED) using poly(catechin) capped-gold nanoparticles (Au@Poly-CH NPs) carrying amfenac [AF; a nonsteroidal anti-inflammatory drug (NSAID)] through effective attenuation of ocular surface tissue damage in dry eyes."3.91Synergistically dual-functional nano eye-drops for simultaneous anti-inflammatory and anti-oxidative treatment of dry eye disease. ( Chang, HT; Harroun, SG; Huang, CC; Huang, YF; Lai, JY; Li, YJ; Luo, LJ; Unnikrishnan, B; Wei, SC, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, YJ1
Luo, LJ1
Harroun, SG1
Wei, SC1
Unnikrishnan, B1
Chang, HT1
Huang, YF1
Lai, JY1
Huang, CC1

Other Studies

1 other study available for amfenac and Dry Eye

ArticleYear
Synergistically dual-functional nano eye-drops for simultaneous anti-inflammatory and anti-oxidative treatment of dry eye disease.
    Nanoscale, 2019, Mar-21, Volume: 11, Issue:12

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biocompatible Materials; Catechin; Cell Line; Corne

2019